- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00534105
Lipid Metabolism in Gestational Diabetes
Study of Lipid Metabolism in Gestational Diabetes
The purpose of this pilot study is to determine if, during pregnancy, women with GDM have an exaggerated lipid response compared to non-gestational diabetics. If a difference is noted, further studies will explore the possibility of screening gestational diabetics during their pregnancy for hyperlipidemia to determine if prenatal screening can predict postpartum risk for hyperlipidemia. In addition the relationship, if any between maternal lipid dysfunction and placental disease will be explored.
This will be a prospective cohort study. As part of routine prenatal care, women receive a one hour glucose challenge test to screen for gestational diabetes. Those women with elevated values then require a three hour glucose tolerance test, which is a diagnostic test for gestational diabetes. All women that are scheduled to receive a three hour GTT will be identified and ask to enroll in this study. 46 women whose three hour GTT is normal and thus do not have GDM, will be compared to 46 women with an abnormal three hour GTT and thus would have the diagnosis of GDM. Enrolled women will have a lipid panel consisting of; total cholesterol, triglycerides, HDL and LDL cholesterol at the time of their fasting glucose blood sample. In addition, a repeat lipid panel will be sent at the time of the third hour sample, to assess changes, if any due to the glucose challenge. Umbilical cord blood samples will be sent in order to obtain newborn lipid profiles. Women in both the GDM and normal groups will be asked to return 6-8 weeks
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The purpose of this pilot study is to determine if, during pregnancy, women with GDM have an exaggerated lipid response compared to non-gestational diabetics. If a difference is noted, further studies will explore the possibility of screening gestational diabetics during their pregnancy for hyperlipidemia to determine if prenatal screening can predict postpartum risk for hyperlipidemia. In addition the relationship, if any between maternal lipid dysfunction and placental disease will be explored. Subsequent studies could also explore the possible perinatal complications associated with elevated lipids and or metabolic syndrome.
C. Experimental Design, Methodology and Expected Results
Study Design:
We propose a prospective cohort design.
Study Population:
All women that are scheduled to receive a three hour GTT to rule out gestational diabetes would be identified and ask to enroll in this study. Specifically, eligible patients will be women who failed their glucose challenge test (GCT) and are scheduled for the follow-up three hour glucose tolerance test (GTT). The GCT is routinely performed among all prenatal care patients at 24-28 wks gestation. The 3 hour GTT requires patients to be fasting overnight. A fasting blood glucose is sampled, and the patients are given a 100 gram glucose drink. Serum glucose samples are then taken at one, two and three hours after the glucose loading. The "exposed" group will be defined as women diagnosed with GDM (elevated glucose values on two or more samples in the three hour GTT). The "unexposed" group will be defined as women with no abnormal glucose values in the three hour GTT.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
Massachusetts
-
Springfield, Massachusetts, Stati Uniti, 01199
- Baystate Medical Center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Pregnancy
- Abnormal one hour glucose challenge test
- "Normal" controls group one hour test between 135 mg% and 150 mg%
- "Gestational diabetic" group with two abnormal values on a 3 hour GTT
Exclusion Criteria:
- History of diagnosis of diabetes, hypertension, heart disease or chronic renal disease
- Prior history of lipid disorder or metabolic syndrome
- Current medications thought to adversely influence glucose tolerance (i.e. prednisone or other steroids and systemic beta-mimetic drugs)
- Non-singleton pregnancy
- < 16 years of age or over 40 years of age
- Not planning to deliver at Baystate Medical Center
- Twins
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: Coorte
- Prospettive temporali: Prospettiva
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
---|---|
Gestational Diabetics
Patients with Gestational Diabetes
|
|
2
Normal pregnant women without gestational diabetes
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Cholesterol
Lasso di tempo: Postpartum
|
Cholesterol values were obtained at least 6 weeks postpartum from the gestational diabetic group and the normal controls
|
Postpartum
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Triglyceride Values
Lasso di tempo: Postpartum
|
Triglyceride values were obtained at least 6 weeks postpartum in both the gestational diabetic group and the normal controls.
|
Postpartum
|
HDL
Lasso di tempo: Postpartum
|
Triglyceride values were obtained at least 6 weeks postpartum in both the gestational diabetic group and the normal controls.
|
Postpartum
|
LDL
Lasso di tempo: Postpartum
|
LDL values were obtained at least 6 weeks postpartum in both the gestational diabetic group and the normal controls.
|
Postpartum
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Glenn R Markenson, MD, Baystate Medical Center
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- IRB07-121
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Total Cholesterol
-
Zimmer BiometAttivo, non reclutanteArtrite reumatoide | Dolore al ginocchio | Osteoartrosi cronica | Necrosi avascolare del condilo femorale | Deformità moderate in varo, valgo o flessioneBelgio, Svizzera, Germania, Israele, Italia
-
Massachusetts General HospitalCompletatoObesità | Perdita di peso | Telemedicina
-
University Hospital, RouenNon ancora reclutamento
-
University of Wisconsin, MadisonCompletatoSovrappeso e obesitàStati Uniti
-
University of British ColumbiaSconosciutoOsteoartrite | Necrosi avascolareCanada
-
DePuy InternationalAttivo, non reclutanteMalattia articolare degenerativa non infiammatoriaStati Uniti, Hong Kong, Malaysia, Regno Unito, Australia, Austria, Belgio, Canada, Germania, Nuova Zelanda, Singapore, Svizzera, Corea, Repubblica di
-
Stryker OrthopaedicsCompletatoProtesi totale di ginocchioDanimarca, Finlandia, Germania, Spagna
-
Seoul National University HospitalReclutamentoMieloma multiploCorea, Repubblica di
-
Smith & Nephew, Inc.Smith & Nephew Orthopaedics AGTerminatoArtrite reumatoide | Artrite degenerativa | Artrite traumaticaBelgio, Francia, Canada, Spagna, Regno Unito
-
Archus Orthopedics, Inc.SconosciutoLombalgia | Malattie della colonna vertebrale | Stenosi spinale lombare | Stenosi spinale | Spondilolistesi | Dolore alla gamba